News & Resources
Read our latest insights and explore our resources, including company updates, articles, white papers, case studies, webinars and more.
-
PCM Trials Improves Retention in a Pompe Disease Clinical Trial
Background Pompe disease (also called Glycogen Storage Disease type II) is an autosomal recessive liposomal storage disorder caused by pathogenic variations in the acid alpha-glucosidase (GAA) gene. The GAA gene contains the information for production and function of the protein GAA. The genetic variation(s) in the GAA gene cause a […]
-
The Largest Parkinson’s Disease Study Ever Attempted is Being Made Possible Only with Mobile Research Nurses
The home-based Trial of Parkinson’s and Zoledronic acid (TOPAZ) is investigating whether a drug used to treat osteoporosis will reduce bone fractures in Parkinson’s disease patients. Due to the limited mobility of many of the participants and the need to enroll so many patients, the only way this trial is […]
-
PCM TRIALS Expands Global Footprint with European Office
New London office allows leader in decentralized clinical trials to better serve Europe at a time when the global pandemic is creating greater demand for in-home services Denver, CO (June 22, 2021) – PCM TRIALS, a leader in utilizing Certified Mobile Research Nurses (CMRNs) for decentralized clinical trials, announced today the opening of […]
-
Watch: “Clinical Trials From Home: The Role of Research Nurses”
May 26, 2021 – Hear what an expert said at OCT East about PCM Trials’ role in the TOPAZ study. “Clinical Trials From Home: The Role of Research Nurses” was presented by Steven R. Cummings, Executive Director, San Francisco Coordinating Center, on Wednesday, May 26th at 10:30 AM ET. Dr. […]
-
Understanding the logistical support necessary for IMP delivery
Speaker Presentation May 5, 2021 PCM Trials was at OCT Europe. Ellen Weiss, Vice President of Business Development for PCM Trials presented “The Nurse Will See You Now: Understanding the logistical support necessary for IMP delivery and sample collection.” She discussed IMP dosing and sampling considerations, showcasing logistic options, best use […]
